Postoperative adjuvant transarterial (chemo)embolisation after liver resection for hepatocellular carcinoma
Appendices
Appendix 1. Search strategies
| Database | Period searched | Search strategy |
| Cochrane Hepato‐Biliary Group Controlled Trials Register | Date will be given at review stage. | (((transcatheter OR transarterial) AND (emboli* OR chemoemboli*)) OR TAE OR TACE) AND (((liver OR hepatic OR hepatocellular OR hepato‐cellular) AND (carcinom* OR cancer* OR neoplasm* OR malign* OR tumo*)) OR HCC) AND (postoperati* OR surg*) |
| Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library | Latest issue. | #1 MeSH descriptor Embolization, Therapeuticexplode all trees #2 ((transcatheter or transarterial) and (emboli* or chemoemboli*)) or TAE or TACE #3 (#1 OR #2) #4 MeSH descriptor Carcinoma, Hepatocellularexplode all trees #5 MeSH descriptor Liver Neoplasmsexplode all trees #6 (((liver OR hepatic OR hepatocellular OR hepato‐cellular) AND (carcinom* OR cancer* OR neoplasm* OR malign* OR tumo*)) OR HCC) #7 (#4 OR #5 OR #6) #8 (postoperati* OR surg*) #9 (#3 AND #7 AND #8) |
| MEDLINE (Ovid SP) | 1948 to the date of search. | 1. exp Embolization, Therapeutic/ 2. (((transcatheter or transarterial) and (emboli* or chemoemboli*)) or TAE or TACE).mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier] 3. 1 or 2 4. exp Carcinoma, Hepatocellular/ 5. exp Liver Neoplasms/ 6. (((liver or hepatic or hepatocellular or hepato‐cellular) and (carcinom* or cancer* or neoplasm* or malign* or tumo*)) or HCC).mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier] 7. 4 or 5 or 6 8. (postoperati* or surg*).mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier] 9. 3 and 7 and 8 10. (random* or blind* or placebo* or meta‐analysis).mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier] 11. 9 and 10 |
| EMBASE (Ovid SP) | 1980 to the date of search. | 1. exp artificial embolism/ 2. (((transcatheter or transarterial) and (emboli* or chemoemboli*)) or TAE or TACE).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 3. 1 or 2 4. exp liver cell carcinoma/ 5. exp liver tumour/ 6. (((liver or hepatic or hepatocellular or hepato‐cellular) and (carcinom* or cancer* or neoplasm* or malign* or tumo*)) or HCC).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 7. 4 or 5 or 6 8. (postoperati* or surg*).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 9. 3 and 7 and 8 10. (random* or blind* or placebo* or meta‐analysis).mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword] 11. 9 and 10 |
| Science Citation Index Expanded (SCIE) | 1945 to the date of search. | #6 #5 AND #4 #5 TS=(random* or blind* or placebo* or meta‐analysis) #4 #3 AND #2 AND #1 #3 TS=(postoperati* or surg*) #2 TS=(((liver or hepatic or hepatocellular or hepato‐cellular) and (carcinom* or cancer* or neoplasm* or malign* or tumo*)) or HCC) #1 TS=(((transcatheter or transarterial) and (emboli* or chemoemboli*)) or TAE or TACE) |
| LILACS | 1982 to the date of search. | (((transcatheter or transarterial) and (emboli$ or chemoemboli$)) or TAE or TACE) [Words] and (((liver or hepatic or hepatocellular or hepato‐cellular) and (carcinom$ or cancer$ or neoplasm$ or malign$ or tumo$)) or HCC) [Words] and (postoperati$ or surg$) [Words] |
| CancerLit | Date will be given at review stage. | Will be reported when searched |
| Wiley Online Library | Date will be given at review stage. | TACE OR TAE OR ((transcatheter OR transarterial) AND (emboli* OR chemoemboli*)) in Article Titles |
| POPLINE | Date will be given at review stage. | TITLE/KEYWORDS: ((transcatheter / transarterial) & (emboli* / chemoemboli*)) / TAE / TACE |
| Chinese Biomedical Literature Database (CBM) | 1978 to the date of search. | Search strategy in Chinese |
| China National Knowledge Infrastructure (CNKI) | 1994 to the date of search. | Search strategy in Chinese |
| CQVIP (www.cqvip.com) | 1989 to the date of search. | Search strategy in Chinese |
| Japan Information Center of Science and Technology File on Science, Technology and Medicine (JICST‐E) | Date will be given at review stage. | Will be reported when search is performed |
| Australasian Medical Index (AMI) | Date will be given at review stage. | Will be reported when search is performed |
| American Society of Clinical Oncology (ASCO) | Date will be given at review stage. | Specify Site Section(s) to search: All of ASCO.org AND TITLE: TACE OR TAE |
| The National Centre for Complementary and Alternative Medicine (NCCAM) | Date will be given at review stage. | Will be reported when search is performed |
| The Allied and Complementary Medicine Database (AMED) | 1985 to the date of search. | Word from article title: TACE OR TAE OR ((transchatheter OR transarterial) AND (emboli$ OR chemoemboli$)) AND Word from article title: liver OR hepatic OR hepato$ AND Word from article title: carcinoma OR cancer OR neoplasm OR malign OR tumo$ OR HCC AND Word from abstract: postoperati$ OR surg$ |
| The Campbell Library (www.campbellcollaboration.org/library.php) | Date will be given at review stage. | Will be reported when search is performed |
| ClinicalTrials.gov Database (clinicaltrials.gov/ct2/search/advanced) | Date will be given at review stage. | Study Results: Study with Results AND Study Types: Interventional Studies AND Conditions: carcinoma OR cancer OR neoplasm OR malign OR tumo* OR HCC AND Interventions: (transarterial OR transcatheter) AND (emboli* OR chemoemboli*) OR TAE OR TACE |
| WHO ICTRP (apps.who.int/trialsearch/AdvSearch.aspx) | Date will be given at review stage. | liver OR hepatic OR hepato in the Title AND carcinoma OR cancer OR neoplasm OR malign OR tumo OR HCC in the Condition AND transarterial AND embolisation OR transcatheter AND embolisation OR TAE OR TACE in the Intervention |
